Drug Profile
CT P25
Alternative Names: CT-P25; Influenza vaccine - CelltrionLatest Information Update: 31 Aug 2023
Price :
$50
*
At a glance
- Originator Celltrion
- Class Antivirals; Vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Influenza virus infections
Most Recent Events
- 31 Aug 2023 Discontinued - Preclinical for Influenza virus infections in South Korea (Parenteral) (Celltrion pipeline, August 2023)
- 28 Mar 2018 No recent reports of development identified for preclinical development in Influenza-virus-infections in South Korea (Parenteral)
- 16 Mar 2016 Preclinical development is ongoing in South Korea (Celltrion pipeline, March 2016)